STAMFORD, Conn., March 30, 2011 /PRNewswire/ — Attendees of the
60th annual American College of Cardiology (ACC) Scientific Session
in New Orleans, La., can see first hand the benefits of
Synapse® 3D from FUJIFILM Medical Systems U.S.A., Inc.
Available for sale in the U.S., Synapse 3D is a comprehensive suite
of clinical applications that is integrated directly into
Synapse® Cardiovascular, Fujifilm’s CVIS / C-PACS. During the
ACC conference Fujifilm will demonstrate the product’s diagnostic
benefits and explain how it can enhance workflow and reporting
while also providing cost savings.
Developed by Fujifilm and utilizing the company’s core
competency in image processing, Synapse 3D can enhance clinical
capabilities with its broad range of applications such as CT
coronary angiography, CT and MR cardiac function analysis, calcium
scoring, and cardiac fusion, allowing fusion of PET, MR, CT, SPECT,
CT Function or MR Function. Other standard tools included are 2D,
3D (includes stenosis and plaque measurements), and 4D viewer,
Sector MPR (multi-planar reconstruction), and Dynamic Data. Using
Fujifilm’s patented algorithms, Synapse 3D delivers image
visualization benefits such as precise segmentation and analysis.
Additionally, the application is powered by an enterprise, scalable
server-based rendering technology that enables the cardiologist to
perform the analysis quickly.
“By combining Fujifilm’s core strength in image processing with
our ability to integrate our 3D product with our CVIS/C-PACS, we
are able to deliver a solution with unrivaled benefits,” said Jim
Morgan, Fujifilm’s Vice President, Medical Informatics. “During
trials and research Synapse 3D has proven to be a powerful and
efficient diagnostic tool, and we’re confident that we will be
seeing widespread adoption by cardiologists.”